INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Faraday Future unveils nine robot models, prices start at $9,990
• Thrive Capital distributes 6.3M Oscar Health shares to limited partners
• Trump announces security deal with Denmark on Greenland